Association between metabolic syndrome and homocysteine levels - gallmet.hu
Macrophages in Atherosclerosis Regression | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Pathophysiology of Circulating Biomarkers and Relationship With Vascular Aging: A Review of the Literature From VascAgeNet Group on Circulating Biomarkers, European Cooperation in Science and Technology Action 18216
Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person | SpringerLink
Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome | Diabetology & Metabolic Syndrome | Full Text
Impaired Homocysteine Metabolism and Atherothrombotic Disease | Laboratory Investigation
Novel metabolic biomarkers of cardiovascular disease | Nature Reviews Endocrinology
Metabolic Syndrome - Ulta Lab Tests
Fibrosis and Inflammatory Markers and Long-Term Risk of Peripheral Artery Disease | Arteriosclerosis, Thrombosis, and Vascular Biology
Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome | Diabetology & Metabolic Syndrome | Full Text
Homocysteine and cardiovascular disease : cause or effect ? 1 , 2 | Semantic Scholar
Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review - ScienceDirect
Atherosclerosis - Wikipedia
Homocysteine – from disease biomarker to disease prevention - Smith - 2021 - Journal of Internal Medicine - Wiley Online Library
IJMS | Free Full-Text | Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
The association between metabolic syndrome components and the development of atherosclerosis | Journal of Human Hypertension
Targeting inflammation in atherosclerosis — from experimental insights to the clinic | Nature Reviews Drug Discovery
Medicina | Free Full-Text | Overview and New Insights into the Metabolic Syndrome: Risk Factors and Emerging Variables in the Development of Type 2 Diabetes and Cerebrocardiovascular Disease
Obesity, Metabolic Syndrome, and Coronary Atherosclerosis | Circulation
The metabolic syndrome - The Lancet
Frontiers | Hyperhomocysteinemia as a Risk Factor for Vascular Contributions to Cognitive Impairment and Dementia
Homocysteine-Mediated Endothelial Dysfunction in Metabolic Syndrome | SpringerLink
Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers - ScienceDirect
IJMS | Free Full-Text | Homocysteine: Its Possible Emerging Role in At-Risk Population Groups
